| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 33,394,109 | 34,768,515 | 28,426,559 | | Cost of Revenue | 26,049,871 | 27,392,929 | 21,886,440 | | | Gross Profit | 7,344,238 | 7,375,586 | 6,540,118 | | | Operating Expenses | | Research Development |
-
|
-
| 59,439 | | Selling General and Administrative | 1,605,094 | 1,963,739 | 1,444,278 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| (32,076) | 189,158 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,739,143 | 5,443,923 | 4,847,244 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (868,758) | 171,598 | 170,402 | | Earnings Before Interest And Taxes | 5,152,260 | 5,652,728 | 4,914,670 | | Interest Expense | 275,749 | 263,904 | 201,619 | | Income Before Tax | 4,876,511 | 5,388,824 | 4,713,051 | | Income Tax Expense | 1,323,601 | 1,404,313 | 1,014,146 | | Minority Interest | 22,918 |
-
| (53,306) | | | | Net Income From Continuing Ops | 3,284,712 | 4,052,786 | 3,748,575 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,284,712 | 4,052,786 | 3,748,575 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,284,712 | $4,052,786 | $3,748,575 |
|
0.31% Nasdaq 0.00%
Income Statement
